1
|
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
|
Crit Care Med
|
1999
|
2.33
|
2
|
Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
|
JAMA
|
1994
|
1.64
|
3
|
Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
|
Antimicrob Agents Chemother
|
1992
|
0.81
|
4
|
Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
|
Clin Pharmacol Ther
|
1999
|
0.75
|
5
|
Aerosol characteristics of 99mTc-pentetic acid (DTPA) and synthetic surfactant (Exosurf).
|
Chest
|
1994
|
0.75
|
6
|
Continuous low volume delivery of intravenous treprostinil via a central venous catheter with a miniature pump in a conscious dog model.
|
J Vasc Access
|
2006
|
0.75
|
7
|
A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy.
|
J Vasc Access
|
2008
|
0.75
|